Arteris (NASDAQ:AIP - Get Free Report) is projected to release its Q2 2025 earnings data after the market closes on Tuesday, August 5th. Analysts expect Arteris to post earnings of ($0.11) per share and revenue of $16.35 million for the quarter.
Arteris Trading Down 8.2%
Arteris stock traded down $0.81 during trading hours on Friday, reaching $9.05. 487,299 shares of the company were exchanged, compared to its average volume of 410,850. The firm has a market cap of $379.92 million, a price-to-earnings ratio of -11.04 and a beta of 1.45. The stock has a 50-day moving average of $8.85 and a 200 day moving average of $8.43. Arteris has a 12 month low of $5.46 and a 12 month high of $12.64.
Insider Transactions at Arteris
In related news, CFO Nicholas B. Hawkins sold 11,000 shares of the company's stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $7.54, for a total value of $82,940.00. Following the completion of the transaction, the chief financial officer directly owned 165,596 shares in the company, valued at approximately $1,248,593.84. This represents a 6.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Saiyed Atiq Raza sold 29,544 shares of the company's stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $10.07, for a total value of $297,508.08. Following the completion of the transaction, the director owned 653,118 shares of the company's stock, valued at $6,576,898.26. The trade was a 4.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 158,366 shares of company stock worth $1,492,653 over the last three months. 29.10% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Arteris stock. Strs Ohio purchased a new stake in Arteris, Inc. (NASDAQ:AIP - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 15,100 shares of the company's stock, valued at approximately $104,000. 64.36% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Rosenblatt Securities reiterated a "buy" rating and set a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st.
Get Our Latest Analysis on AIP
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.